 |
A case report of brain cancer (primary central nervous system lymphoma) developing in a person being treated with Tysabri (natalizumab, Biogen Idec and Elan Pharmaceuticals) has been published.
To read more, as reported by the US National MS Society, click here.
Source: US National MS Society
|